Jose-Carlos Gutiérrez-Ramos
Technik-/Wissenschafts-/F&E-Leiter bei DANAHER CORPORATION
Vermögen: 4 Mio $ am 30.04.2024
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Aoife Brennan | M | 48 |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | 8 Jahre |
Matthew McGrew | M | 52 | - | |
Rainer Blair | M | 60 | 14 Jahre | |
Steven Rales | M | 72 | 41 Jahre | |
Nick Leschly | M | 51 |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | 8 Jahre |
Noubar Afeyan | M | 60 |
Cogen Immune Medicine, Inc.
Cogen Immune Medicine, Inc. Pharmaceuticals: MajorHealth Technology Cogen Immune Medicine, Inc. develops immune modulation therapeutics which control immune system. Its platform includes therapeutics, vaccines, clinical decision making, and immune health. The company was founded by Noubar B. Afeyan in 2017 and is headquartered in Cambridge, MA. | 6 Jahre |
Richard Shea | M | 72 | 21 Jahre | |
Kevin Lee | M | 55 | 12 Jahre | |
Santiago Arroyo | M | 64 | 7 Jahre | |
Mitchell Rales | M | 67 | 41 Jahre | |
Alistair Milnes | M | 50 | 3 Jahre | |
Michael Powell | M | 69 |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | 7 Jahre |
Michael Skynner | M | 55 | 11 Jahre | |
Jessica Mega | M | 49 | 5 Jahre | |
Michael Thomas Ropacki | M | - | 5 Jahre | |
Thomas J. Adam | M | - | 7 Jahre | |
Stephen Sands | M | 67 | - | |
Christopher Bouda | M | 47 | 8 Jahre | |
Brian Ellis | M | 58 | 8 Jahre | |
Alan Spoon | M | 72 | 25 Jahre | |
A. Sanders | M | 61 | 3 Jahre | |
Gregory Winter | M | 73 | 15 Jahre | |
Teri List-Stoll | F | 61 | 13 Jahre | |
Raymond Stevens | M | 60 | 7 Jahre | |
Travis Thompson | M | - | 6 Jahre | |
Elias Zerhouni | M | 72 | 15 Jahre | |
Linda Filler | F | 64 | 20 Jahre | |
Shantanu Narayen | M | 60 | 11 Jahre | |
John Schwieters | M | 84 | 21 Jahre | |
Thomas Freyman | M | 69 | 4 Jahre | |
Peter Barrett | M | 71 | 7 Jahre | |
Feroz Dewan | M | 47 | 2 Jahre | |
Richard Kender | M | 68 | 5 Jahre | |
Helen Hobbs | M | 71 | 13 Jahre | |
Jim Smith | M | 64 | 10 Jahre | |
Janice Bourque | F | 67 | 5 Jahre | |
James F. O'Reilly | M | - | - | |
Jennifer Perry | F | - | - | |
A. JOSEPH ALEX | M | - | - | |
Travis Taylor | M | - | 3 Jahre | |
Elizabeth Gordon | M | - |
Excaliard Pharmaceuticals, Inc.
Excaliard Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Excaliard Pharmaceuticals, Inc. manufactures, develops therapeutics for the treatment of scarring and fibrotic disorders. The company was founded by John Gordon Foulkes and Nicholas M. Dean in 2006 and is headquartered in New York, NY. | - |
Georgeann Couchara | F | 48 | 20 Jahre | |
Steve Danehy | M | - | 12 Jahre | |
Caroline Kurtz | M | - | 8 Jahre | |
Jonathan Bryant | M | - | 4 Jahre | |
Duane van Arsdale | M | - | 4 Jahre | |
Carrie Strom | F | - | 4 Jahre | |
Susan Hohenleitner | F | - | 4 Jahre | |
Zafar Qadir | M | - | 4 Jahre | |
John Bedford | M | - | 3 Jahre | |
Agnieszka Cieplinska | F | - | 5 Jahre | |
Alex de Winter | M | - | 4 Jahre | |
James Sutcliffe | M | 68 | 1 Jahre | |
Nicholas Keen | M | 56 | 7 Jahre | |
Pardis Sabeti | M | 48 | 5 Jahre | |
Pascal Touchon | M | 61 |
Cogen Immune Medicine, Inc.
Cogen Immune Medicine, Inc. Pharmaceuticals: MajorHealth Technology Cogen Immune Medicine, Inc. develops immune modulation therapeutics which control immune system. Its platform includes therapeutics, vaccines, clinical decision making, and immune health. The company was founded by Noubar B. Afeyan in 2017 and is headquartered in Cambridge, MA. | - |
Sadik Kassim | M | - | 3 Jahre | |
David Berry | M | 47 |
Cogen Immune Medicine, Inc.
Cogen Immune Medicine, Inc. Pharmaceuticals: MajorHealth Technology Cogen Immune Medicine, Inc. develops immune modulation therapeutics which control immune system. Its platform includes therapeutics, vaccines, clinical decision making, and immune health. The company was founded by Noubar B. Afeyan in 2017 and is headquartered in Cambridge, MA. | - |
Pierre Legault | M | 63 | 5 Jahre | |
William King | M | 56 | 26 Jahre | |
Nigel Crockett | M | 59 | 5 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Jeffrey Kindler | M | 68 | 8 Jahre | |
Craig Wheeler | M | 63 | 14 Jahre | |
William Steere | M | 87 | 28 Jahre | |
Simba Gill | M | 60 | 8 Jahre | |
Michelle Robertson | F | 57 | 3 Jahre | |
Ann Thorell | F | 56 | 1 Jahre | |
Todd Shegog | M | 59 | 3 Jahre | |
Bruce Downey | M | 76 | 11 Jahre | |
Lee Kalowski | M | 43 | 6 Jahre | |
Alejandra Carvajal | F | 50 | 4 Jahre | |
Alison D. Silva | F | 46 |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | 3 Jahre |
Louis J. Arcudi | M | 63 |
Peptimmune, Inc.
Peptimmune, Inc. BiotechnologyHealth Technology Peptimmune was founded in 2002 with technology from the laboratories of Dr. Jack Strominger, Higgins Professor of Biochemistry at Harvard University; and Dr. Hidde Ploegh, from the Whitehead Institute for Biomedical Research. Peptimmune has therapeutics in clinical development for the treatment of multiple sclerosis. Peptimmune's flagship program in multiple sclerosis features PI-2301, which has the opportunity to replace Copaxone® (Teva Pharmaceuticals), the world's leading first-line therapy for the treatment of MS. Peptimmune has broad expertise in MHC Class II molecules and their role in antigen presentation and modulation of immune responses. The Company exploits its proprietary DEEP Technology (Directed Expansion of Epitope Permutation) to design peptides and peptide mixtures for development as therapeutics, diagnostic kits, and as reagents for antibody generation. The Company is building a unique suite of expertise in the manufacture and control of peptide copolymer-based drug products. | 7 Jahre |
Lord Darzi | M | 63 | 5 Jahre | |
Ankit Mahadevia | M | 43 | 3 Jahre | |
Amy Schulman | F | 63 | 6 Jahre | |
David Epstein | M | 62 | 6 Jahre | |
Ganesh Venkataraman Kaundinya | M | 57 | 17 Jahre | |
David Perry | M | 56 | 6 Jahre | |
John Cox | M | 61 |
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Repertoire Immune Medicines, Inc. operates as a clinical-stage biotechnology company. It focuses on the immune system to prevent, treat, and cure cancer, autoimmune disorders, and infectious diseases. The company was founded by Noubar Afeyan and is headquartered in Cambridge, MA. | 3 Jahre |
Maiken Keson-Brookes | F | 52 | - | |
John Hohneker | M | 64 | 2 Jahre | |
Luca Scavo | M | 57 | 1 Jahre | |
Marc Tessier-Lavigne | M | 64 | 4 Jahre | |
Paul W. May | M | - |
Avidia, Inc.
Avidia, Inc. Pharmaceuticals: MajorHealth Technology Avidia, Inc. developed pharmaceutical products. The company developed a novel, proprietary class of small therapeutic proteins. The company was headquartered in Mountain View, CA. | - |
Elizabeth Stoner | M | 73 | 13 Jahre | |
Robert Landry | M | 60 | 4 Jahre | |
Thomas Paul Koestler | M | 71 | 9 Jahre | |
Ronald O. Robison | M | - | - | |
Theo Melas-Kyriazi | M | 64 | 6 Jahre | |
Olivier Brandicourt | M | 68 | 13 Jahre | |
Bruce A. Leicher | M | 68 | 10 Jahre | |
James Sulat | M | 73 | 11 Jahre | |
Dana George Mead | M | 88 | 12 Jahre | |
M. Anthony Burns | M | 81 | 25 Jahre | |
Walter Lohr | M | 80 | 41 Jahre | |
Robert N. Burt | M | 86 | 11 Jahre | |
Marsha Fanucci | F | 70 | 11 Jahre | |
Georges Gemayel | M | 64 | 4 Jahre | |
Scott Cundy | M | - | 3 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 86 | 86,00% |
Vereinigtes Königreich | 16 | 16,00% |
Spanien | 1 | 1,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Jose-Carlos Gutiérrez-Ramos
- Persönliches Netzwerk